156 related articles for article (PubMed ID: 22827640)
1. Drug resistance-related microRNAs in esophageal cancer.
Hong L; Han Y; Lu Q; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2012 Nov; 12(11):1487-94. PubMed ID: 22827640
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer.
Yang W; Ma J; Zhou W; Zhou X; Cao B; Zhang H; Zhao Q; Fan D; Hong L
Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1151-1163. PubMed ID: 28838272
[TBL] [Abstract][Full Text] [Related]
3. Function of miRNA in controlling drug resistance of human cancers.
Hong L; Yang Z; Ma J; Fan D
Curr Drug Targets; 2013 Sep; 14(10):1118-27. PubMed ID: 23834156
[TBL] [Abstract][Full Text] [Related]
4. Prognosis-related microRNAs in esophageal cancer.
Hong L; Han Y; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2014 Apr; 14(4):483-9. PubMed ID: 24506707
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis-related molecular targets in esophageal cancer.
Hong L; Li S; Han Y; Du J; Zhang H; Li J; Zhao Q; Wu K; Fan D
Expert Opin Investig Drugs; 2011 May; 20(5):637-44. PubMed ID: 21443389
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.
Hong L; Han Y; Yang J; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2014 Aug; 14(8):1103-11. PubMed ID: 24707835
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer.
Yang W; Ma J; Zhou W; Cao B; Zhou X; Yang Z; Zhang H; Zhao Q; Fan D; Hong L
Expert Opin Ther Targets; 2017 Nov; 21(11):1063-1075. PubMed ID: 28994330
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21: a therapeutic target for reversing drug resistance in cancer.
Hong L; Han Y; Zhang Y; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Ther Targets; 2013 Sep; 17(9):1073-80. PubMed ID: 23865553
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance-related miRNAs in hepatocellular cancer.
Hong L; Han Y; Zhang H; Zhao Q; Wu K; Fan D
Expert Rev Gastroenterol Hepatol; 2014 Mar; 8(3):283-8. PubMed ID: 24502538
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis-related microRNAs in colon cancer.
Hong L; Han Y; Zhou Y; Nita A
Expert Opin Biol Ther; 2013 Jan; 13(1):77-84. PubMed ID: 23163807
[TBL] [Abstract][Full Text] [Related]
11. MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancer.
Xia H; Chen S; Chen K; Huang H; Ma H
Biomed Pharmacother; 2014 Oct; 68(8):951-8. PubMed ID: 25465153
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in esophageal cancer (review).
He B; Yin B; Wang B; Xia Z; Chen C; Tang J
Mol Med Rep; 2012 Sep; 6(3):459-65. PubMed ID: 22751839
[TBL] [Abstract][Full Text] [Related]
13. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer.
Kestens C; Siersema PD; van Baal JW
World J Gastroenterol; 2016 Jan; 22(1):1-7. PubMed ID: 26755856
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor: an important target in esophageal cancer.
Hong L; Han Y; Brain L
Expert Opin Ther Targets; 2013 Oct; 17(10):1179-85. PubMed ID: 23855932
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy.
Ko MA; Zehong G; Virtanen C; Guindi M; Waddell TK; Keshavjee S; Darling GE
Ann Thorac Surg; 2012 Oct; 94(4):1094-102; discussion 1102-3. PubMed ID: 22939244
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway.
Hamano R; Miyata H; Yamasaki M; Kurokawa Y; Hara J; Moon JH; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
Clin Cancer Res; 2011 May; 17(9):3029-38. PubMed ID: 21248297
[TBL] [Abstract][Full Text] [Related]
17. Role of micro-RNAs in drug resistance of multiple myeloma.
Abdi J; Jian H; Chang H
Oncotarget; 2016 Sep; 7(37):60723-60735. PubMed ID: 27494872
[TBL] [Abstract][Full Text] [Related]
18. miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression.
Wang Y; Zhao Y; Herbst A; Kalinski T; Qin J; Wang X; Jiang Z; Benedix F; Franke S; Wartman T; Camaj P; Halangk W; Kolligs FT; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2016 Nov; 264(5):804-814. PubMed ID: 27501171
[TBL] [Abstract][Full Text] [Related]
19. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.
Jin YY; Chen QJ; Xu K; Ren HT; Bao X; Ma YN; Wei Y; Ma HB
Mol Cell Biochem; 2016 Nov; 422(1-2):161-170. PubMed ID: 27644195
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies.
Seo HA; Moeng S; Sim S; Kuh HJ; Choi SY; Park JK
Cells; 2019 Dec; 9(1):. PubMed ID: 31861937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
